Clinical Trial Update: Patient's Anastrozole Compliance to Therapy Programme

View source ↗

Summary

This update reports that a clinical trial investigating a patient's adherence to anastrozole therapy for breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: TERMINATED